New Zealand markets closed
  • NZX 50

    11,677.75
    +35.90 (+0.31%)
     
  • NZD/USD

    0.6435
    +0.0021 (+0.32%)
     
  • NZD/EUR

    0.6080
    -0.0002 (-0.04%)
     
  • ALL ORDS

    7,541.50
    +38.00 (+0.51%)
     
  • ASX 200

    7,338.70
    +37.20 (+0.51%)
     
  • OIL

    80.65
    +0.67 (+0.84%)
     
  • GOLD

    1,821.20
    +11.60 (+0.64%)
     
  • NASDAQ

    11,994.26
    -47.64 (-0.40%)
     
  • FTSE

    7,556.23
    -2.26 (-0.03%)
     
  • Dow Jones

    34,429.88
    +34.88 (+0.10%)
     
  • DAX

    14,529.39
    +39.09 (+0.27%)
     
  • Hang Seng

    19,320.62
    +645.27 (+3.46%)
     
  • NIKKEI 225

    27,783.91
    +6.01 (+0.02%)
     
  • NZD/JPY

    86.4260
    +0.3000 (+0.35%)
     

Here's Why the Post-Pandemic World May Be Even Better for This Vaccine Maker

Here's Why the Post-Pandemic World May Be Even Better for This Vaccine Maker

Moderna (NASDAQ: MRNA) is the name behind one of last year's top-selling pharmaceutical products. Does that mean Moderna's sales will plunge? In fact, Moderna's best days may not be in the past -- but in the future.